跳至主要内容
临床试验/NCT01436058
NCT01436058已完成1 期

Phase 1 Study of Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Patients With Ankle Joint Osteoarteritis

Royan Institute1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2010年9月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
6
试验地点
1
主要终点
safety

研究概览

简要总结

Ankle osteoarthritis is a joint condition which results from damage and loss of the cartilage in a joint. Treatment options for ankle osteoarthritis are usually aimed at controlling pain and limiting motion that provokes the pain. Nonsurgical treatment approaches are tried first. If unsuccessful, surgical options are considered. Stem cell therapy is one of the therapeutic options that can repair the damaged cartilage. Bone marrow derived mesenchymal stem cells have showed the capacity of bone and cartilage regeneration.

详细描述

In this clinical study the investigators aim to investigate the safety of intra-articular injection of cultured autologous bone marrow derived mesenchymal stem cells (BM-MSCs) to the ankle joint in patients with severe ankle osteoarthritis. Patients will undergo bone marrow aspiration and will receive cultured BM-MSCs one month later. Patients will be assessed clinically with scoring system (FAO, VAS, WOMAC) preoperatively as well as 2 and 6 months postoperative to measure pain reduction and joint function improvement. Paraclinical studies (X-Ray and MRI) will be performed before and 6 months after treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Osteoarthritis diagnosed by MRI
  • •End stage osteoarthritis candidate for total ankle replacement

排除标准

  • •Pregnancy or lactating
  • •Positive tests for HIV, HCV, HBV
  • •Active neurologic disorder
  • •End organ damage
  • •Uncontrolled endocrine disorder

研究组 & 干预措施

stem cell recipient

Experimental

patients with ankle joint osteoarthritis

干预措施: mesenchymal stem cell (Biological)

结局指标

主要结局

safety

时间窗: 6 months

Evaluate Safety of intra-articular injection of autologous cultured mesenchymal stem cells in patients with ankle osteoarthritis (time frame : baseline, 2 months, 6 months)by filling the check list of side effects

次要结局

  • pain(6 months)
  • defect(6 months)
  • physical function(6 months)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验